Comparison of Treatments in Venous Insufficiency

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Maarit Venermo, Helsinki University Central Hospital
ClinicalTrials.gov Identifier:
NCT01298908
First received: February 17, 2011
Last updated: October 1, 2012
Last verified: October 2012

February 17, 2011
October 1, 2012
October 2007
December 2012   (final data collection date for primary outcome measure)
Recanalization or reflux of the treated venous trunk [ Time Frame: at 1 and 12 months ] [ Designated as safety issue: No ]
Results will be verified by Duplex scanning
Same as current
Complete list of historical versions of study NCT01298908 on ClinicalTrials.gov Archive Site
  • Symptom relief [ Time Frame: at 1 and 12 months ] [ Designated as safety issue: No ]
    Symptoms will be evaluated by using CEAP-classification and degree of disability
  • Complications related to procedure [ Time Frame: at 1 and 12 months ] [ Designated as safety issue: Yes ]
    At 1 month follow-up immediate complications will be recorded. At 12 months follow-up appearance of late complications and pain and incapacity for work due to the procedure will be recorded.
  • Quality of life [ Time Frame: at 1 and 12 months ] [ Designated as safety issue: No ]
    Quality of life is evaluated with two questionnaires: Aberdeen (which is a 13-item questionnaire with categories related specially to disadvantages caused by varicose veins) and 15D (a questionnaire with categories related to general quality of life)
Same as current
Not Provided
Not Provided
 
Comparison of Treatments in Venous Insufficiency
The Utility of Novel Ambulatory Treatment Techniques in Venous Insufficiency

Randomized controlled trial, a method used to implement the random allocation sequence is numbered containers.

The aim of the study is to compare operative treatment, ultrasound guided laser ablation and ultrasound guided foam sclerotherapy in occluding/ablating of insufficiency in great saphenous trunks. On the grounds of the available data, the study hypothesis is that using laser or operative treatment more than 20 percent better outcome can be achieved compared to foam sclerotherapy.

In operative treatment the great saphenous vein will be removed after flush ligation by femoral vein and stripping of the trunk. In intravenous laser treatment a thin laser fiber is inserted through a tiny distal entry point. The probe is guided into place using ultrasound and the procedure is performed under local tumescence anesthesia. Laser energy is delivered to seal the faulty vein. Ultrasound guided foam sclerotherapy involves an injection of foam (sodium tetradecyl sulfate mixed with air according to the Thessari method) directly into the venous trunk under ultrasound control. In each group patients will use supportive treatment stockings 2 weeks after treatment. The patients in all groups are followed up one year by ultrasound scanning.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Venous Insufficiency
  • Procedure: Operative treatment
    In operative treatment the great saphenous vein will be removed after flush ligation by femoral vein and stripping of the trunk.
    Other Name: Vein stripping
  • Procedure: Laser ablation
    In intravenous laser treatment a thin laser fiber is inserted through a tiny distal entry point. The probe is guided into place using ultrasound and the procedure is performed under local tumescence anesthesia. Laser energy is delivered to seal the faulty vein.
    Other Name: Ultrasound guided laser ablation
  • Procedure: Foam sclerotherapy
    Ultrasound guided foam sclerotherapy involves an injection of foam (sodium tetradecyl sulfate mixed with air according to the Thessari method) directly into the venous trunk under ultrasound control.
    Other Name: Ultrasound guided foam sclerotherapy
  • Operative treatment
    vein stripping
    Intervention: Procedure: Operative treatment
  • Laser ablation
    Ultrasound guided laser ablation
    Intervention: Procedure: Laser ablation
  • Foam sclerotherapy
    Ultrasound guided foam sclerotherapy
    Intervention: Procedure: Foam sclerotherapy
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
231
December 2012
December 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • patients with chronic superficial vein insufficiency
  • patient must be 20-70 years old
  • degree of difficulty of vein insufficiency C2-C4
  • average diameter of refluxing great saphenous vein 4 -10 mm
  • patient is agreeable to the study

Exclusion Criteria:

  • peripheral atherosclerotic occlusive disease
  • lymphoedema
  • severe concomitant disease
  • venous ulcers or unclassified skin changes
  • BMI more than 40
  • pregnancy
  • allergy to the foam used in sclerotherapy or to local anaesthetics
  • coagulation disorder
  • bilateral vein insufficiency (equal symptoms)
Both
20 Years to 70 Years
No
Contact information is only displayed when the study is recruiting subjects
Finland
 
NCT01298908
Version 1.0 - Sep 6th, 2006
No
Maarit Venermo, Helsinki University Central Hospital
Helsinki University Central Hospital
Not Provided
Study Director: Maarit Venermo, MD,PhD Department of Vascular Surgery, Helsinki University Central Hospital
Helsinki University Central Hospital
October 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP